Seattle

Recurrent UTI in Women: AUA/SUFU Guidelines

Una Lee, MD, FPMRS, urologist and researcher at Virginia Mason Medical Center, reviews the 2019 AUA/SUFU guidelines on uncomplicated recurrent urinary tract infection (rUTI) in women, summarizes the evidence underlying these guidelines, and discusses their relevance to clinical scenarios. She first details complications clinicians may experience, such as antibiotic resistant infections and stressed patients. Dr. Lee then discusses the guideline recommendations: clinicians should use first-line therapy; should obtain urinalysis, urine culture, and sensitivity; may offer patient-initiated treatment; should use as short a duration of antibiotics as possible; may offer cranberry prophylaxis for women with rUTIs; should obtain a full patient history; and should not treat asymptomatic bacteriuria. She then argues that although molecular diagnostics are available, the sensitive microorganism detection they provide is associated with overtreatment, overdiagnosis, and confusion due to our current lack of data on which microorganisms are necessary or harmful for a healthy urinary microbiome. Dr. Lee concludes by discussing cranberries and the treatment capabilities of the proanthocyanidins (PACs) they contain, noting that antibiotics are still considered to be more effective, however.

Read More

Improving Specificity of PSA Screening with Serum and Urine Markers – Who Doesn’t Need a Prostate Biopsy?

Daniel W. Lin, MD, Chief of Urologic Oncology at the University of Washington, discusses improving the specificity of PSA screening using serum and urine markers to determine which patients do not need a prostate biopsy. He lists the ideal biomarker characteristics, including sensitivity and specificity, correlation with disease outcome, reproducibility, low cost, quick and easy assay, and high negative predictive value. He then discusses some of the major studies done on pre-diagnosis biomarkers for prostate cancer, highlighting how PHI score, 4Kscore, and PCA3, among other markers, all significantly reduce the biopsy rate compared with older diagnostics like percent free PSA. Dr. Lin concludes by noting how urologists can further reduce unnecessary biopsies through smart screening strategies, including biennial rather than annual PSA screenings and considering not biopsying men with low early PSA scores.

Read More

Pelvic Organ Prolapse Surgery in Women: Defining Success and Patient Satisfaction

Una Lee, MD, FPMRS, urologist and researcher at Virginia Mason Medical Center, reviews the evidence on non-mesh alternatives for stress urinary incontinence (SUI). She provides an overview of the causes of female SUI, presents an effective treatment tree addressing both overactive bladder and stress incontinence, and discusses treatment options. Dr. Lee encourages physicians to consider how they present treatment decisions in order to allow patients to make the choice that fits best for them. In addition to covering all possible risks and benefits, she advises physicians to also educate patients on their condition and help manage their expectations for treatment outcomes.

Read More